ARCHIVES

Bishop Completes Term As NCAB Chairman; Terms Of Five Extended Awaiting W.H. Action.

This article is from The Cancer Letter archive.

Vol. 26 No. 08 | February 25, 2000

Download PDF Visit The Full Archive

Related Articles

Also in this 8-page issue: Richard Pazdur named director of FDA’s new Office of Oncology Drug Products.

April 22, 2005

‘Helping Smokers Quit’ Program Launched By NCI, Pharmacist Group

June 27, 1986

About Need For Cancer Research Funding

February 3, 1995

New Understanding of drug Resistance Exciting Revolution

September 17, 1982

AACR Statement on Precancers Plays Key Role in NCI Agenda

May 30, 2003

In Brief: NCAB Will Consider Holding “Circuit Rider” Meetings; Kaplan Asked to Speak On Hybridomas

May 1, 1981